Zydus Lifesciences shares jump 6% on buyback buzz; co announces $166 mn Assertio acquisition
Shares of Zydus Lifesciences jumped around 6% after the company announced that its board of directors will meet on May 19 (Tuesday) to consider a buyback of shares. The pharma company also announced the acquisition of US-based cancer drug-maker Assertio for $166.4 million. Zydus Lifesciences shares climbed to an intraday high of Rs 993.80 on…